With its conventional receptor, CXCR4, CXCL12 modifies immunity by immune cell recruitment and polarization, such as altering tumor-associated macrophages and T cells, eventually promoting malignancies [12–15]. The gene discussed is CXCL12; the disease is neoplasm.